logo
Intelligence
Tracking
Tools
logo
Intelligence
Tracking
Tools

Pfizer Completes Acquisition Of Global Blood Therapeutics 

Oct 05, 2022•about 3 years ago

Acquiring Company

Pfizer

Acquired Company

Global Blood Therapeutics

New YorkpharmaceuticalsTherapeuticsBiotechnologyHealth Care

Description

Pfizer Inc. (NYSE: PFE) announced today the completion of its acquisition of Global Blood Therapeutics, Inc. (GBT), a biopharmaceutical company dedicated to the discovery, development and delivery of life-changing treatments that provide hope to underserved patient communities starting with sickle cell disease (SCD). The acquisition reinforces Pfizer’s commitment to SCD, building on a 30-year legacy in the rare hematology space.

Company Information

Company

Pfizer

Location

66 Hudson Blvd E

New York, New York, United States

About

Seagen is a biotechnology company focused on developing innovative therapies for cancer treatment. The company specializes in antibody-drug conjugates and has a portfolio of targeted therapies. Seagen is recognized for its advancements in cancer care and plays a significant role in the oncology market. Its dedication to research and development underpins its success in the competitive biotech landscape.

Related People

Sign in to view contact details

Sign in to view contact details

Sign in to view contact details

M&A Insights

Based on deal data
Integration timeline
70% of M&A integrations take 12-24 months to complete
Tech stack consolidation
83% of merged companies consolidate technology vendors within first year
Post-acquisition investment
Companies increase IT spending by 23% on average after acquisitions
Success factor
M&A deals with strong technology integration plans are 2.5x more likely to succeed